Rabnil MUPS 20 mg (MUPS Tablet)
Unit Price: ৳ 10.00 (5 x 10: ৳ 500.00)
Strip Price: ৳ 100.00
Medicine Details
Category | Details |
---|---|
Generic | Rabeprazole sodium |
Company | Benham pharmaceuticals ltd |
Also available as |
Title and Categories
- Rabnil MUPS 20 mg Gastro-resistant Tablet
- Pharmaceuticals
- Proton Pump Inhibitor
Indications
- Treatment of active duodenal ulcer
- Treatment of active benign gastric ulcer
- Symptomatic treatment of erosive or ulcerative gastro-esophageal reflux disease (GERD)
- Long-term management of gastro-esophageal reflux disease (GERD maintenance)
- Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
- Treatment of Zollinger-Ellison Syndrome
- In combination with antibacterial therapeutic regimens for the eradication of Helicobacter pylori in patients with peptic ulcer disease
Pharmacology
- Suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase
Dosage
- Oral dose for active duodenal ulcer and active benign gastric ulcer is 20 mg once daily in the morning
- Oral dose for erosive or ulcerative GERD is 20 mg once daily for four to eight weeks
- Maintenance dose of rabeprazole sodium 20 mg or 10 mg once daily for long-term management
- Treatment of Zollinger-Ellison Syndrome starting with 60 mg once a day, titrated upwards to 120 mg/day
Administration
Tablets should be taken in the morning before eating and swallowed whole
Interaction
- Potential interaction with compounds whose absorption is pH dependent
- Co-administration with ketoconazole or itraconazole may decrease antifungal plasma levels
- No interaction with liquid antacids observed
Contraindications
- Hypersensitivity to the active substance or excipients
- Contra-indicated in pregnancy and during breastfeeding
Side Effects
- Headache
- Diarrhea
- Abdominal pain
- Vomiting
- Constipation
- Dry mouth
- Changes in appetite
- Muscle pain
- Drowsiness
- Dizziness
Pregnancy & Lactation
US FDA pregnancy category 'C', not recommended during breastfeeding
Precautions & Warnings
- Symptomatic response does not exclude the presence of gastric or esophageal malignancy
- Regular surveillance for long-term patients
- Possibility of increased risk of hip, wrist, and spine fracture with long-term use, especially in the elderly
- Hypomagnesaemia and vitamin B12 absorption concerns
- Risk of cross-hypersensitivity reactions with other proton pump inhibitors
- Monitoring for blood dyscrasias and hepatic enzyme abnormalities
Use in Special Populations
- No dose adjustment for patients with renal or hepatic impairment
- Not recommended for use in children due to lack of safety and efficacy data
Overdose Effects
- Maximum established exposure up to 60 mg twice daily
- Effects are generally minimal and reversible without further medical intervention
- No specific antidote known, treatment should be symptomatic and supportive
Storage Conditions
Keep below 30°C temperature, away from light & moisture, out of the reach of children
Chemical Structure
Molecular Formula: C18H21N3O3S
Commonly Asked Questions
- What is Rabnil MUPS 20 mg MUPS Tablet?
- What is it used for?
- What are the side effects?
- How should it be taken?
- Can it be taken during pregnancy or breastfeeding?
- What to do in case of overdose?
- How long should it be taken?
- Side effects related to bone problems
- Co-administration with vitamin D
- Quick Tips for usage
Related Brands
- Cosmorab 20 mg (Tablet (Enteric Coated)) - cosmo-pharma-laboratories-ltd
- Rabetol 20 mg (Tablet (Enteric Coated)) - biogen-pharmaceuticals-ltd
- Rabefour 20 mg (Capsule (Enteric Coated)) - albion-laboratories-limited
- Xorel MUPS 20 mg (MUPS Tablet) - ibn-sina-pharmaceuticals-ltd
- Tagus 10 mg (Tablet (Enteric Coated)) - healthcare-pharmaceuticals-ltd